[在急性支气管炎中合理使用抗生素治疗]
1Maladies Infectieuses et Tropicales, Hôpital de l'Archet, BP 689, F-06012 Nice, France.
Medecine et maladies infectieuses
|April 15, 2024
概括
急性支气管炎通常是病毒性,罕见的细菌参与,这证明了初始抗生素治疗的合理性. 慢性支气管炎恶化的管理需要仔细考虑超级感染风险和潜在的辅助疗法.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 健康患者的急性支气管炎主要是病毒性,很少涉及细胞内细菌,如Mycoplasma pneumoniae.
- 与急性支气管炎相比,慢性支气管炎 (AECB) 的急性恶化存在不同的病因和治疗考虑因素.
研究的目的:
- 审查当前对急性支气管炎和AECB病原体参与的理解.
- 讨论在管理这些呼吸道疾病时适当使用抗生素和其他治疗方法.
主要方法:
- 对急性支气管炎和AECB研究的文献综述.
- 对病原体流行率和治疗指南的分析.
- 评估抗生素,动疗和皮质类固醇的作用.
主要成果:
- 病毒病因在急性支气管炎中占主导地位,这证明了宏类或四环素的谨慎使用是合理的.
- AECB的管理涉及类似于急性支气管炎的初始管理,有可能出现需要治疗性抗生素治疗的二次细菌超级感染.
- 在适当使用抗生素时,区分AECB的早期和晚期至关重要.
- 相关的治疗方法,如动疗和皮质类固醇,可能会影响疾病的发展过程,但缺乏可靠的临床试验评估.
结论:
- 对急性支气管炎和AECB的抗生素选择必须以特定的临床背景和可疑的病原体为指导.
- 需要进一步的研究来评估非抗生素辅助治疗在支气管炎管理中的有效性.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.7K
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
33.0K
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
01:17Drugs Used in Lower Respiratory Disorders: Overview
428
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
428
01:28Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
256
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
256
01:29Acute Respiratory Failure-V
136
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
136
01:16Drugs Used in Upper Respiratory Disorders: Overview
237
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
237